Stem Cell Oversight Committee

The Stem Cell Oversight Committee reviews research applications involving human pluripotent stem cells that have been derived from and embryonic source and/or will be transferred into humans or non-human animals to ensure compliance with Chapter 12, Section F of the TCPS 2.


Susan Babcock
Independent Consultant
Member, Panel on Research Ethics (PRE)

Mohamed Abou-el-Enein, MD, PhD, MSPH
Executive Director, USC/CHLA Cell Therapy Program
Associate Professor of Clinical Medicine (Oncology), Pediatrics and Stem Cell Biology & Regenerative Medicine, Keck School of Medicine
University of Southern California

Jessica Esseltine, PhD
Assistant Professor of Cancer and Development, Faculty of Medicine, Division of BioMedical Sciences
Memorial University of Newfoundland

Myriam Hemberger
Professor in the Departments of Biochemistry & Molecular Biology and Medical Genetics, University of Calgary Program Director of the Precision Medicine & Disease Mechanisms program at the Alberta Children’s Hospital Research Institute (ACHRI)

Rosario Isasi
Research Assistant Professor
Dr. John T. Macdonald Foundation Department of Human Genetics
University of Miami Miller School of Medicine

Blake Murdoch, JD, MBA
Research Associate, Health Law Institute
University of Alberta, Faculty of Law

William Pastor, PhD
Assistant Professor, Department of Biochemistry
McGill University

Mahmoud Pouladi, PhD
Associate Professor of Medical Genetics, University of British Columbia
Investigator, BC Children’s Research Institute

Mojgan Rastegar, PhD, MSc, BSc, DEA
Professor, Department Biochemistry & Medical Genetics,
Rady Faculty of Health Sciences, University of Manitoba
Scientist, Children’s Hospital Research Institute of Manitoba

Karun Singh, PhD
Senior Scientist, Krembil Research Institute, University of Health Network (UHN)
Associate Professor, Faculty of Medicine, University of Toronto
Adjunct Professor, Department of Psychiatry and Behavioral Sciences, McMaster University

Denis Claude Roy, MD, FRCPC
Full professor of medicine, University of Montreal; Chief executive officer, CellCAN and Scientific director of the Centre of Excellence for Cellular Therapy at Montreal’s Maisonneuve-Rosemont Hospital

Amy Wong, PhD
Scientist, Programme in Developmental & Stem Cell Biology, Toronto Hospital for Sick Children
Assistant Professor, Department of Laboratory Medicine & Pathobiology, Temerty Faculty of Medicine, University of Toronto

Tammy J. Clifford
Vice-President Research - Learning Health Systems

Acting President (effective April 8, 2024)

Ex-officio, non-voting member

Date modified: